Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 291

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk

Open access
Windecker, Stephan, Latib, Azeem, Kedhi, Elvin, Kirtane, Ajay J., Kandzari, David E., Mehran, Roxana, Price, Matthew J., Abizaid, Alexandre, Simon, Daniel I., Worthley, Stephen G., Zaman, Azfar, Hudec, Martin, Poliacikova, Petra, Abdul Ghapar, A. Kahar bin, Selvaraj, Kamaraj, Petrov, Ivo, Mylotte, Darren, Pinar, Eduardo, Moreno, Raul, Fabbiocchi, Franco, Pasupati, Sanjeevan, Kim, Hyo-Soo, Aminian, Adel, Tie, Charles, Wlodarczak, Adrian, Hur, Seung-Ho, Marx, Steven O., Jankovic, Ivana, Brar, Sandeep, Bousquette, Lisa, Liu, Minglei, Stone, Gregg W. · 2020 · New England Journal of Medicine

Abstract

BACKGROUND: Polymer-free drug-coated stents provide superior clinical outcomes to bare-metal stents in patients at high bleeding risk who undergo percutaneous coronary intervention (PCI) and are treated with 1 month of dual antiplatelet therapy. Data on the use of polymer-based drug-eluting stents, as compared with polymer-free drug-coated stents, in such patients are limited. METHODS: In an international, randomized, single-blind trial, we compared polymer-based zotarolimus-eluting stents with polymer-free umirolimus-coated stents in patients at high bleeding risk. After PCI, patients were treated with 1 month of dual antiplatelet therapy, followed by single antiplatelet therapy. The primary outcome was a safety composite of death from cardiac causes, myocardial infarction, or stent thrombosis at 1 year. The principal secondary outcome was target-lesion failure, an effectiveness composite of death from cardiac causes, target-vessel myocardial infarction, or clinically indicated target-lesion revascularization. Both outcomes were powered for noninferiority. RESULTS: A total of 1996 patients at high bleeding risk were randomly assigned in a 1:1 ratio to receive zotarolimus-eluting stents (1003 patients) or polymer-free drug-coated stents (993 patients). At 1 year, the primary outcome was observed in 169 of 988 patients (17.1%) in the zotarolimus-eluting stent group and in 164 of 969 (16.9%) in the polymer-free drug-coated stent group (risk difference, 0.2 percentage points; upper boundary of the one-sided 97.5% confidence interval [CI], 3.5; noninferiority margin, 4.1; P = 0.01 for noninferiority). The principal secondary outcome was observed in 174 patients (17.6%) in the zotarolimus-eluting stent group and in 169 (17.4%) in the polymer-free drug-coated stent group (risk difference, 0.2 percentage points; upper boundary of the one-sided 97.5% CI, 3.5; noninferiority margin, 4.4; P = 0.007 for noninferiority). CONCLUSIONS: Among patients at high bleeding risk who received 1 month of dual antiplatelet therapy after PCI, use of polymer-based zotarolimus-eluting stents was noninferior to use of polymer-free drug-coated stents with regard to safety and effectiveness composite outcomes. (Funded by Medtronic; ONYX ONE ClinicalTrials.gov number, NCT03344653.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1910021

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 291

Metadata

Authors
Windecker, S., Latib, A., Kedhi, E., Kirtane, A. J., Kandzari, D. E., Mehran, R., Price, M. J., Abizaid, A., Simon, D. I., Worthley, S. G., Zaman, A., Hudec, M., Poliacikova, P., Abdul Ghapar, A. K. B., Selvaraj, K., Petrov, I., Mylotte, D., Pinar, E., Moreno, R., Fabbiocchi, F., Pasupati, S., Kim, H.-S., Aminian, A., Tie, C., Wlodarczak, A., Hur, S.-H., Marx, S. O., Jankovic, I., Brar, S., Bousquette, L., Liu, M., & Stone, G. W.
Venue
New England Journal of Medicine
Published
2020-03-26
Volume
382
Issue
13
Pages
1208-1218
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3005734342
Cited by
291
References
19
FWCI
42.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. https://app.cochat.ai/papers/10.1056/nejmoa1910021
The paper
Windecker, S., Latib, A., Kedhi, E., Kirtane, A. J., Kandzari, D. E., Mehran, R., Price, M. J., Abizaid, A., Simon, D. I., Worthley, S. G., Zaman, A., Hudec, M., Poliacikova, P., Abdul Ghapar, A. K. B., Selvaraj, K., Petrov, I., Mylotte, D., Pinar, E., Moreno, R., . . . Stone, G. W. (2020). Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1910021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.